U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Fibrinogen, CTCAE

MedGen UID:
288327
•Concept ID:
C1561955
•
Finding

Recent clinical studies

Therapy

Efficacy and Safety Evaluation of 177Lu-FAP-2286 in the Treatment of Advanced Lung Cancer.
Xie Y, Ma J, Tang W, Zhang Y, Zhang C, Chen Y
Clin Nucl Med 2024 Sep 1;49(9):830-837. Epub 2024 May 26 doi: 10.1097/RLU.0000000000005297. PMID: 39102810
Risk stratification for infection during immunosuppressive therapy in patients with lupus nephritis: A nested case-control study.
Lu J, Wu Y, Xue J, Hao C
Lupus 2024 Jul;33(8):828-839. Epub 2024 Apr 25 doi: 10.1177/09612033241248722. PMID: 38662532
Effect of Food on the Pharmacokinetics and Safety of a Novel c-Met Inhibitor SCC244: A Randomized Phase I Study in Healthy Subjects.
Wu J, Xu H, Li H, Ma L, Chen J, Yuan F, Sheng L, Liu C, Chen W, Li X
Drug Des Devel Ther 2023;17:761-769. Epub 2023 Mar 10 doi: 10.2147/DDDT.S388846. PMID: 36925997Free PMC Article
A collagen-fibrin patch (Tachosil®) for the prevention of symptomatic lymphoceles after pelvic lymphadenectomy in women with gynecologic malignancies: a randomized clinical trial.
Grimm C, Polterauer S, Helmy S, Cibula D, Zikan M, Reinthaller A, Tempfer C
BMC Cancer 2014 Aug 30;14:635. doi: 10.1186/1471-2407-14-635. PMID: 25175029Free PMC Article
Phase I/II clinical study on safety and antivascular effects of paclitaxel encapsulated in cationic liposomes for targeted therapy in advanced head and neck cancer.
Strieth S, Dunau C, Michaelis U, Jäger L, Gellrich D, Wollenberg B, Dellian M
Head Neck 2014 Jul;36(7):976-84. Epub 2013 Dec 11 doi: 10.1002/hed.23397. PMID: 23733258

Prognosis

Risk stratification for infection during immunosuppressive therapy in patients with lupus nephritis: A nested case-control study.
Lu J, Wu Y, Xue J, Hao C
Lupus 2024 Jul;33(8):828-839. Epub 2024 Apr 25 doi: 10.1177/09612033241248722. PMID: 38662532
Immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomes.
Holtzman NG, Xie H, Bentzen S, Kesari V, Bukhari A, El Chaer F, Lutfi F, Siglin J, Hutnick E, Gahres N, Ruehle K, Ahmad H, Shanholtz C, Kocoglu MH, Badros AZ, Yared JA, Hardy NM, Rapoport AP, Dahiya S
Neuro Oncol 2021 Jan 30;23(1):112-121. doi: 10.1093/neuonc/noaa183. PMID: 32750704Free PMC Article

Clinical prediction guides

Efficacy and Safety Evaluation of 177Lu-FAP-2286 in the Treatment of Advanced Lung Cancer.
Xie Y, Ma J, Tang W, Zhang Y, Zhang C, Chen Y
Clin Nucl Med 2024 Sep 1;49(9):830-837. Epub 2024 May 26 doi: 10.1097/RLU.0000000000005297. PMID: 39102810
Risk stratification for infection during immunosuppressive therapy in patients with lupus nephritis: A nested case-control study.
Lu J, Wu Y, Xue J, Hao C
Lupus 2024 Jul;33(8):828-839. Epub 2024 Apr 25 doi: 10.1177/09612033241248722. PMID: 38662532
Effect of Food on the Pharmacokinetics and Safety of a Novel c-Met Inhibitor SCC244: A Randomized Phase I Study in Healthy Subjects.
Wu J, Xu H, Li H, Ma L, Chen J, Yuan F, Sheng L, Liu C, Chen W, Li X
Drug Des Devel Ther 2023;17:761-769. Epub 2023 Mar 10 doi: 10.2147/DDDT.S388846. PMID: 36925997Free PMC Article
Immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomes.
Holtzman NG, Xie H, Bentzen S, Kesari V, Bukhari A, El Chaer F, Lutfi F, Siglin J, Hutnick E, Gahres N, Ruehle K, Ahmad H, Shanholtz C, Kocoglu MH, Badros AZ, Yared JA, Hardy NM, Rapoport AP, Dahiya S
Neuro Oncol 2021 Jan 30;23(1):112-121. doi: 10.1093/neuonc/noaa183. PMID: 32750704Free PMC Article

Supplemental Content

Table of contents

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...